Nyxoah (NYXH NASDAQ) stock market data APIs
$1.2544
0(0%)
as of October 14, 2026
Try our APIs with
free plan!
Nyxoah Financial Data Overview
Price chart is built with
Anychart
Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Prev. Close
1.2544
Open
1.2576
High
1.2619
Low
1.2357
52 wk Range
1.235-6
Market Cap
127 M
Shares Outstanding
102 M
Revenue
21 663 K
EPS
-0.67
Beta
1.001
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Nyxoah data using free add-ons & libraries
Get Nyxoah Fundamental Data
Nyxoah Fundamental data includes:
- Net Revenue: 21 663 K
- EBITDA: -82 744 000
- Earnings Per Share: -2
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-08-05
- EPS/Forecast: -0.47
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Nyxoah News
New
Schrodinger (SDGR) Surges 7.6%: Is This an Indication of Further Gains?
Schrodinger, Inc. SDGR shares soared 7.6% in the last trading session to close at $32.6. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares...
At a glance: stocks gapping down premarket
[Wall Street sign, New York City, USA] mbbirdy/E+ via Getty Images Here's a quick look at the stocks that are seeing gap-down moves before the bell on Tuesday. Stock index futures were mixed on Tues...
Nyxoah Appoints Liam Kelly as Chief Executive Officer
Nyxoah REGULATED INFORMATION INSIDE INFORMATION Nyxoah Appoints Liam Kelly as Chief Executive Officer Further strengthening the Company's strategic U.S. presence and focus Mont-Saint-Guibert, Bel...
Nyxoah (NYXH) Begins BREATHE Study. Can Real-World Evidence Drive Genio Adoption?
Nyxoah SA (NASDAQ:NYXH) announced the first patient implantation in BREATHE on September 7. The prospective, single-arm U.S. post-approval study will evaluate Genio hypoglossal-nerve stimulation in ad...
Get Nyxoah fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.